KRYS
USDKrystal Biotech Inc. Common Stock
$203.260+7.795 (3.988%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$195.465
High
$212.980
Low
$195.465
Volume
0.66M
Company Fundamentals
Market Cap
5.9B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.32M
Exchange
NMS
Currency
USD
52-Week Range
Low $122.8Current $203.260High $212.98
Related News
Analyst Upgrades
Citigroup Maintains Neutral on Krystal Biotech, Raises Price Target to $198
Citigroup analyst Yigal Nochomovitz maintains Krystal Biotech with a Neutral and raises the price target from $166 to $198.
View more
Analyst Upgrades
Chardan Capital Maintains Buy on Krystal Biotech, Raises Price Target to $220
Chardan Capital analyst Geulah Livshits maintains Krystal Biotech with a Buy and raises the price target from $216 to $220.
View more
GlobeNewswire
Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results
$97.8 million in 3Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in 4Q Updated U.S. VYJUVEK label expands eligible patient population and
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.